According to the subgroup analysis, patients with diabetic neuropathic pain appeared to have a better response from ALC compared with those due to a non-diabetic cause, which is consistent with recent systematic reviews [26,27]
Disclosure Giorgio Cruccu received a research grant, consulting fees and payments for lectures from Sigma-Tau of Alfasigma Group, and consulting fees from Angelini, Biogen, and Mundipharma
Our bodies dont work in isolation
If your sleep issues stem primarily from elevated evening cortisol or chronic stress, slightly different dosing may help
Tambin se ha realizado un subanlisis del estudio SELECT31 sobre los efectos renales de 2,4mg semanales de semaglutida que incluy pacientes con obesidad y enfermedad cardiovascular sin DM2 (n=17.604) asignados aleatoriamente a semaglutida 2,4mg o placebo durante 182 semanas